FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291131275> ?p ?o ?g. }

• W4291131275 endingPage "198" @default.
• W4291131275 startingPage "198" @default.
• W4291131275 abstract "Mitogen-activated protein kinase-8-interacting protein 2 (MAPK8IP2) is a scaffold protein that modulates MAPK signal cascades. Although MAPK pathways were heavily implicated in prostate cancer progression, the regulation of MAPK8IP2 expression in prostate cancer is not yet reported. We assessed MAPK8IP2 gene expression in prostate cancer related to disease progression and patient survival outcomes. MAPK8IP2 expression was analyzed using multiple genome-wide gene expression datasets derived from The Cancer Genome Atlas (TCGA) RNA-sequence project and complementary DNA (cDNA) microarrays. Multivariable Cox regressions and log-rank tests were used to analyze the overall survival outcome and progression-free interval. MAPK8IP2 protein expression was evaluated using the immunohistochemistry approach. The quantitative PCR and Western blot methods analyzed androgen-stimulated MAPK8IP2 expression in LNCaP cells. In primary prostate cancer tissues, MAPK8IP2 mRNA expression levels were significantly higher than those in the case-matched benign prostatic tissues. Increased MAPK8IP2 expression was strongly correlated with late tumor stages, lymph node invasion, residual tumors after surgery, higher Gleason scores, and preoperational serum prostate-specific antigen (PSA) levels. MAPK8IP2 upregulation was significantly associated with worse overall survival outcomes and progression-free intervals. In castration-resistant prostate cancers, MAPK8IP2 expression strongly correlated with androgen receptor (AR) signaling activity. In cell culture-based experiments, MAPK8IP2 expression was stimulated by androgens in AR-positive prostate cancer cells. However, MAPK8IP2 expression was blocked by AR antagonists only in androgen-sensitive LNCaP but not castration-resistant C4-2B and 22RV1 cells. These results indicate that MAPK8IP2 is a robust prognostic factor and therapeutic biomarker for prostate cancer. The potential role of MAPK8IP2 in the castration-resistant progression is under further investigation." @default.
• W4291131275 created "2022-08-13" @default.
• W4291131275 creator A5020637697 @default.
• W4291131275 creator A5026017650 @default.
• W4291131275 creator A5038929713 @default.
• W4291131275 creator A5039126001 @default.
• W4291131275 creator A5046092151 @default.
• W4291131275 creator A5061760479 @default.
• W4291131275 date "2023-01-01" @default.
• W4291131275 modified "2023-09-30" @default.
• W4291131275 title "Scaffold protein MAPK8IP2 expression is a robust prognostic factor in prostate cancer associated with AR signaling activity" @default.
• W4291131275 cites W128880540 @default.
• W4291131275 cites W1513110684 @default.
• W4291131275 cites W1550230214 @default.
• W4291131275 cites W1837246685 @default.
• W4291131275 cites W1967990571 @default.
• W4291131275 cites W1977918192 @default.
• W4291131275 cites W2015851233 @default.
• W4291131275 cites W2019478674 @default.
• W4291131275 cites W2025183726 @default.
• W4291131275 cites W2025183773 @default.
• W4291131275 cites W2033017336 @default.
• W4291131275 cites W2035613198 @default.
• W4291131275 cites W2037932659 @default.
• W4291131275 cites W2043913457 @default.
• W4291131275 cites W2051025382 @default.
• W4291131275 cites W2055241999 @default.
• W4291131275 cites W2084903524 @default.
• W4291131275 cites W2088590359 @default.
• W4291131275 cites W2107633226 @default.
• W4291131275 cites W2109502519 @default.
• W4291131275 cites W2114108194 @default.
• W4291131275 cites W2134351031 @default.
• W4291131275 cites W2136159134 @default.
• W4291131275 cites W2139773658 @default.
• W4291131275 cites W2148047023 @default.
• W4291131275 cites W2149441684 @default.
• W4291131275 cites W2155483393 @default.
• W4291131275 cites W2159303181 @default.
• W4291131275 cites W2171912431 @default.
• W4291131275 cites W2318869368 @default.
• W4291131275 cites W2326458159 @default.
• W4291131275 cites W2604796563 @default.
• W4291131275 cites W2614667111 @default.
• W4291131275 cites W2795989238 @default.
• W4291131275 cites W2902488470 @default.
• W4291131275 cites W2904355372 @default.
• W4291131275 cites W2944403040 @default.
• W4291131275 cites W2945673523 @default.
• W4291131275 cites W2982051641 @default.
• W4291131275 cites W3000532606 @default.
• W4291131275 cites W3009076554 @default.
• W4291131275 cites W3017289957 @default.
• W4291131275 cites W3093363809 @default.
• W4291131275 cites W3109418113 @default.
• W4291131275 cites W3122470240 @default.
• W4291131275 cites W3132915896 @default.
• W4291131275 cites W3134153391 @default.
• W4291131275 cites W3159316585 @default.
• W4291131275 cites W3161922707 @default.
• W4291131275 cites W3170981509 @default.
• W4291131275 cites W3184193217 @default.
• W4291131275 cites W3185871101 @default.
• W4291131275 cites W4206298742 @default.
• W4291131275 doi "https://doi.org/10.4103/aja202240" @default.
• W4291131275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35975362" @default.
• W4291131275 hasPublicationYear "2023" @default.
• W4291131275 type Work @default.
• W4291131275 citedByCount "4" @default.
• W4291131275 countsByYear W42911312752022 @default.
• W4291131275 countsByYear W42911312752023 @default.
• W4291131275 crossrefType "journal-article" @default.
• W4291131275 hasAuthorship W4291131275A5020637697 @default.
• W4291131275 hasAuthorship W4291131275A5026017650 @default.
• W4291131275 hasAuthorship W4291131275A5038929713 @default.
• W4291131275 hasAuthorship W4291131275A5039126001 @default.
• W4291131275 hasAuthorship W4291131275A5046092151 @default.
• W4291131275 hasAuthorship W4291131275A5061760479 @default.
• W4291131275 hasBestOaLocation W42911312751 @default.
• W4291131275 hasConcept C121608353 @default.
• W4291131275 hasConcept C126322002 @default.
• W4291131275 hasConcept C143998085 @default.
• W4291131275 hasConcept C193270364 @default.
• W4291131275 hasConcept C2776235491 @default.
• W4291131275 hasConcept C2779723316 @default.
• W4291131275 hasConcept C2780192828 @default.
• W4291131275 hasConcept C502942594 @default.
• W4291131275 hasConcept C61367390 @default.
• W4291131275 hasConcept C71924100 @default.
• W4291131275 hasConcept C86803240 @default.
• W4291131275 hasConcept C87874733 @default.
• W4291131275 hasConceptScore W4291131275C121608353 @default.
• W4291131275 hasConceptScore W4291131275C126322002 @default.
• W4291131275 hasConceptScore W4291131275C143998085 @default.
• W4291131275 hasConceptScore W4291131275C193270364 @default.
• W4291131275 hasConceptScore W4291131275C2776235491 @default.
• W4291131275 hasConceptScore W4291131275C2779723316 @default.
• W4291131275 hasConceptScore W4291131275C2780192828 @default.

• next